GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,591.50p
   
  • Change Today:
      8.00p
  • 52 Week High: 1,711.20
  • 52 Week Low: 1,316.00
  • Currency: UK Pounds
  • Shares Issued: 4,114.88m
  • Volume: 1,236,191
  • Market Cap: £65,488m
  • RiskGrade: 129

Covid-19 cases surge during latest week due to BA.4 and BA.5 Covid-19 sub-variants

By Alexander Bueso

Date: Friday 01 Jul 2022

LONDON (ShareCast) - (Sharecast News) - The number of new coronavirus cases in Britain jumped again during the preceding week, likely due to the more infectious BA.4 and BA.5 variants of the Omicron variant of Covid-19.

According to fresh figures from the Office for National Statistics, over 3.0m people in the country caught Omicron last week, although hospitalisations had not risen by as much and deaths fell slightly.

During the preceding month, cases had increased by 30%.

The news came as some countries, such as France, moved to reintroduce certain health measures such as mask wearing on public transport, by recommending that they be used.

In other countries, such as Spain, they remained mandatory on public transport, as well as in Italy.

For her part, Dr. Mary Ramsay, of the UK Health Security Agency, told the Associated Press that "it is also sensible to wear a face covering in crowded enclosed places".

There was a silver lining, as according to Dr.Jonathan Van-Tam, a former British deputy chief medical officer, who told the BBC that Covid-19 was now "much, much, much closer to seasonal flu".

Dr.Van-Tam however added that authorities should be vigilant for any indications that the virus might provoked more severe sickness.

On 24 June, the UK Health Security Agency estimated that BA.4 and BA.5 now accounted for 22% and 39% of infections in Britain, respectively.

BA.5 appeared to be growing 35.1% faster than BA.2 and BA.4 about 19.1% more quickly.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

GSK Market Data

Currency UK Pounds
Share Price 1,591.50p
Change Today 8.00p
% Change 0.51 %
52 Week High 1,711.20
52 Week Low 1,316.00
Volume 1,236,191
Shares Issued 4,114.88m
Market Cap £65,488m
RiskGrade 129

GSK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
78.09% below the market average78.09% below the market average78.09% below the market average78.09% below the market average78.09% below the market average
39.62% below the sector average39.62% below the sector average39.62% below the sector average39.62% below the sector average39.62% below the sector average
Price Trend
20.69% above the market average20.69% above the market average20.69% above the market average20.69% above the market average20.69% above the market average
71.93% above the sector average71.93% above the sector average71.93% above the sector average71.93% above the sector average71.93% above the sector average
Income
44.86% above the market average44.86% above the market average44.86% above the market average44.86% above the market average44.86% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Growth
26.1% below the market average26.1% below the market average26.1% below the market average26.1% below the market average26.1% below the market average
40.54% above the sector average40.54% above the sector average40.54% above the sector average40.54% above the sector average40.54% above the sector average

What The Brokers Say

Strong Buy 8
Buy 5
Neutral 9
Sell 2
Strong Sell 0
Total 24
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

GSK Dividends

  Latest Previous
  Q4 Q3
Ex-Div 22-Feb-24 16-Nov-23
Paid 11-Apr-24 11-Jan-24
Amount 16.00p 14.00p

Trades for 19-Apr-2024

Time Volume / Share Price
15:03 29 @ 1,591.50p
15:03 580 @ 1,591.50p
15:03 700 @ 1,591.50p
15:03 230 @ 1,591.50p
15:03 146 @ 1,591.50p

GSK Key Personnel

CEO Emma Walmsley

Top of Page